Back to search

United Kingdom· GB-APID-41126511000001108

Mounjaro 5mg/0.5ml solution for injection pre-filled pens

A tirzepatide product containing tirzepatide, registered in United Kingdom by Eli Lilly and Company Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC A10BX16

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedMounjaro 5mg/0.5ml solution for injec…ATCA10BX16REGISTER NO.GB-APID-4112651100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Tirzepatide is registered in 15 of 19 countries.

Countries holding a registration under ATC A10BX16 (tirzepatide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Tirzepatide · ATC A10BX16

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tirzepatide costs, country by country.

Normalised to the WHO defined daily dose (1.4 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tirzepatide · price per daily dose (1.4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$45.12
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Tirzepatide
Manufacturer
Eli Lilly and Company Ltd
Country
United Kingdom (GB)
ATC code
A10BX16
ATC class
Tirzepatide
Defined daily dose
1.4 mg, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    05014602101862

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tirzepatide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tirzepatide products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Mounjaro, Mounjaro Kwikpen
  • Liechtenstein · Mounjaro, Mounjaro Kwikpen
  • Norway · Mounjaro, Mounjaro Kwikpen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/36536899-c5cc-45ba-9eb6-3d12b2ca7a66
GET /v1/drugs/36536899-c5cc-45ba-9eb6-3d12b2ca7a66?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "41126511000001108",
  "desc": "Mounjaro 5mg/0.5ml solution for injection pre-filled pens (Eli Lilly and Company Ltd)",
  "form": "Solution for injection",
  "vpid": "41152611000001107",
  "source": "dmd",
  "vtm_id": "41145911000001106",
  "strength": "10 mg",
  "substance": "Tirzepatide",
  "ingredient": "Tirzepatide",
  "supplier_code": "2075101000001100"
}

See everything about tirzepatide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.